An independent, nonpartisan record of every U.S. tariff and the revenue it generates.

Tariff Tracker pulls live customs and trade data from Treasury, Census, and the Federal Register, presented exactly as the government publishes it; daily, with full historical context back to January 2025.

Updated each business dayOpen data, public sourcesNo advertising, no tracking
Total Tariff Revenue · Jan 2025 – June 2026iCent-accurate cumulative figure from the U.S. Treasury's Monthly Treasury Statement (Table 4, Customs Duties line). Reflects net receipts after refunds and drawbacks.
$337,061,360,303.91
+$26.5B since June 2026 (provisional · all customs receipts)iFrom the Daily Treasury Statement. Bundles Customs Duties with Merchandise Processing Fee and Harbor Maintenance Tax, so this figure is slightly broader than the MTS number above. Updates each business day.
Today's Customs Receipts
$334M
▼ -$330M vs prior business day
Month-to-Date Revenue
$334M
August 2026
Calendar YTD Revenue
$99,484M
YTD 2026
Most Recent Federal Register Alert
Large Diameter Welded Pipe From the Republic of Korea: Preliminary Results and Rescission, in Part, of Countervailing Duty Administrative Review; 2024
Aug 4, 2026 · Notice
Tariffed Product LinesiCount of HTS codes carrying an active trade-action surcharge (Section 232, Section 301, executive surcharges, etc.). A 'product line' is one 10-digit HTS code. Placeholder figure pending Yale Budget Lab effective-rate parsing.
8,217
of 29,583 total product lines

Itemized Duties

Browse customs duties by 10-digit HTS code. Click any code to see its monthly revenue breakdown since January 2025.

‹ Back to all codes

2934.91.00.00

Aminorex (INN), brotizolam (INN), clotiazepam (INN), cloxazolam (INN), dextromoramide (INN), haloxazolam (INN), ketazolam (INN), mesocarb (INN), oxazolam (INN), pemoline (INN), phendimetrazine (INN), phenmetrazine (INN) and sufentanil (INN); salts thereof

$7K cumulative duties since January 2025

MonthDuties Collected
Mar 2025$5K
Feb 2026$2K